Skip to main content

Table 3 Genes that are differentially expressed in at least one treatment with a > 1.5 fold difference in FPKM values between retinoic acid and retinol treatment in LMH cells. Cells treated with retinoic acid for 1 h (RA_1h), were compared with cell treated with retinol for 1 h (RO_1h), and cells treated with retinoic acid for 4 h (RA_4h), were compared with cell treated with retinol for 4 h (RO_4h)

From: Multi-species transcriptome meta-analysis of the response to retinoic acid in vertebrates and comparative analysis of the effects of retinol and retinoic acid on gene expression in LMH cells

Symbol FPKM(RA_1h) FPKM(RA_4h) FPKM(RO_1h) FPKM(RO_4h) max(1 h)/min(1 h) max(4 h)/min(4 h)
AADACL4L3 0.110 0.260 0.039 0.228 2.800 1.140
BARL 0.310 0.708 0.165 0.626 1.874 1.131
CYP26B1 0.072 0.152 0.017 0.102 4.223 1.491
HIC1 0.599 0.810 0.219 0.514 2.728 1.575
HOXA5 0.137 0.369 0.091 0.280 1.507 1.318
LOC100858306a 0.025 0.077 0.011 0.066 2.170 1.169
LOC101749099a 0.277 0.199 0.147 0.357 1.885 1.796
LOC107052653a 0.062 0.328 0.041 0.256 1.503 1.279
LOC107054934a 0.878 3.019 0.554 2.576 1.586 1.172
LOC112530143a 0.176 0.613 0.112 0.489 1.568 1.253
LOC112530664a 0.113 0.072 0.077 0.149 1.467 2.063
LOC112531076 0.334 0.492 0.160 0.623 2.093 1.266
LOC112531791a 2.526 4.686 1.514 7.300 1.669 1.558
LOC112531797 0.337 0.856 0.199 0.799 1.699 1.071
RARB 0.053 0.387 0.023 0.324 2.305 1.195
TBX21 0.426 1.418 0.216 0.694 1.970 2.042
VSIG10L 0.038 0.127 0.021 0.181 1.825 1.422
  1. AADACL4L3 arylacetamide deacetylase like 3C, BARL bile acid receptor-like, CYP26B1 Cytochrome P450 26B1, HIC1 Hypermethylated in cancer 1 protein, HOXA5 Homeobox protein Hox-A5, LOC100858306 ncRNA, LOC101749099 ncRNA, LOC107052653 ncRNA, LOC107054934 ncRNA, LOC112530143 ncRNA, LOC112530664 ncRNA, LOC112531076 zinc finger protein 664-like, LOC112531791 ncRNA, LOC112531797 atherin-like, RARB Retinoic acid receptor beta, TBX21 T-box transcription factor TBX21, VSIG10L V-set and immunoglobulin domain-containing protein 10-like
  2. ancRNAs
\